Diseases

T442X6D

Underdosing of ganglionic blocking drugs, subsequent encounter

T442X6S

Underdosing of ganglionic blocking drugs, sequela

T443X1A

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter

T444X2S

Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela

T443X1D

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter

T443X1S

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), sequela

T443X2A

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter

T443X2D

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter

T443X2S

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela

T443X3A

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter

T443X3D

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter

T443X3S

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela

T443X4A

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter

T443X4D

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter

T443X4S

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela

T443X5A

Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter

T443X5D

Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter

T443X5S

Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela

T443X6A

Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter

T443X6D

Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter

T443X6S

Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela

T444X1A

Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter

T444X1D

Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter

T444X1S

Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela

T444X2A

Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter

T444X2D

Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter

T444X3A

Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter

T444X3D

Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter

T444X3S

Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela

T444X4A

Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter

T444X4D

Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter

T444X4S

Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela

T444X5A

Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter

T444X5D

Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter

T444X5S

Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela

T444X6A

Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter

T444X6D

Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter

T444X6S

Underdosing of predominantly alpha-adrenoreceptor agonists, sequela

T445X1A

Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter

T445X1D

Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter

T445X1S

Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela

T445X2A

Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter

T445X2D

Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter

T445X2S

Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela

T445X3A

Poisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter

T445X3D

Poisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter

T445X3S

Poisoning by predominantly beta-adrenoreceptor agonists, assault, sequela

T445X4A

Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter

T445X4D

Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter

T445X4S

Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, sequela

T445X5A

Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter

T445X5D

Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter

T445X5S

Adverse effect of predominantly beta-adrenoreceptor agonists, sequela

T445X6A

Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter

T445X6D

Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter

T445X6S

Underdosing of predominantly beta-adrenoreceptor agonists, sequela

T446X1A

Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), initial encounter

T446X1D

Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter

T446X1S

Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), sequela

T446X2A

Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, initial encounter

T446X2D

Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, subsequent encounter

T446X2S

Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, sequela

T446X3A

Poisoning by alpha-adrenoreceptor antagonists, assault, initial encounter

T446X3D

Poisoning by alpha-adrenoreceptor antagonists, assault, subsequent encounter

T446X3S

Poisoning by alpha-adrenoreceptor antagonists, assault, sequela

T446X4A

Poisoning by alpha-adrenoreceptor antagonists, undetermined, initial encounter

T446X4D

Poisoning by alpha-adrenoreceptor antagonists, undetermined, subsequent encounter

T446X4S

Poisoning by alpha-adrenoreceptor antagonists, undetermined, sequela

T446X5A

Adverse effect of alpha-adrenoreceptor antagonists, initial encounter

T446X5D

Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter

T446X5S

Adverse effect of alpha-adrenoreceptor antagonists, sequela

T446X6A

Underdosing of alpha-adrenoreceptor antagonists, initial encounter

T446X6D

Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter

T446X6S

Underdosing of alpha-adrenoreceptor antagonists, sequela

T447X1A

Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), initial encounter

T447X1D

Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter

T447X1S

Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), sequela

T447X2A

Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter

T447X2D

Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter

T447X2S

Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, sequela

T447X3A

Poisoning by beta-adrenoreceptor antagonists, assault, initial encounter

T447X3D

Poisoning by beta-adrenoreceptor antagonists, assault, subsequent encounter

T447X3S

Poisoning by beta-adrenoreceptor antagonists, assault, sequela

T447X4A

Poisoning by beta-adrenoreceptor antagonists, undetermined, initial encounter

T447X4D

Poisoning by beta-adrenoreceptor antagonists, undetermined, subsequent encounter

T447X4S

Poisoning by beta-adrenoreceptor antagonists, undetermined, sequela

T447X5A

Adverse effect of beta-adrenoreceptor antagonists, initial encounter

T447X5D

Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter

T447X5S

Adverse effect of beta-adrenoreceptor antagonists, sequela

T447X6A

Underdosing of beta-adrenoreceptor antagonists, initial encounter

T447X6D

Underdosing of beta-adrenoreceptor antagonists, subsequent encounter

T447X6S

Underdosing of beta-adrenoreceptor antagonists, sequela

T448X1A

Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), initial encounter

T448X1D

Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), subsequent encounter

T448X1S

Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), sequela

T448X2A

Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, initial encounter

T448X2D

Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, subsequent encounter

T448X2S

Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, sequela

T448X3A

Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, initial encounter

T448X3D

Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, subsequent encounter